Alistair Strathern - Alert Sample

Alert Sample

View the Parallel Parliament page for Alistair Strathern

Information between 28th October 2024 - 7th November 2024

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.

Calendar
Wednesday 13th November 2024 4 p.m. Alistair Strathern (Labour - Hitchin) Westminster Hall debate - Westminster Hall Subject: Government support for kinship carers View calendar - Add to calendar

Division Votes
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 356 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 371 Noes - 77
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 359 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 373 Noes - 110
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 367 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 400 Noes - 122
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 368 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 400 Noes - 120
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 360 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 378 Noes - 116
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 356 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 383 Noes - 184
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 364 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 454 Noes - 124
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 371 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 401 Noes - 120
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 368 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 455 Noes - 125
6 Nov 2024 - Budget Resolutions - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 362 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 450 Noes - 120
29 Oct 2024 - Great British Energy Bill - View Vote Context Alistair Strathern voted Aye - in line with the party majority and in line with the House One of 343 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 361 Noes - 111
29 Oct 2024 - Great British Energy Bill - View Vote Context Alistair Strathern voted No - in line with the party majority and in line with the House One of 345 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 115 Noes - 361
29 Oct 2024 - Great British Energy Bill - View Vote Context Alistair Strathern voted No - in line with the party majority and in line with the House One of 343 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 124 Noes - 361
29 Oct 2024 - Great British Energy Bill - View Vote Context Alistair Strathern voted No - in line with the party majority and in line with the House One of 346 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 96 Noes - 353

Speeches
Alistair Strathern speeches from: Small Boat Crossings Alistair Strathern contributed 1 speech (82 words) Wednesday 6th November 2024 - Commons Chamber Home Office

Written Answers
Trastuzumab Deruxtecan Asked by: Alistair Strathern (Labour - Hitchin) Monday 28th October 2024 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what recent discussions he has had on the provision of Enhurtu to Her2 low metastatic breast cancer patients. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) The Department’s ministers and officials have had a number of recent meetings at which the issue of the availability of Enhertu for the treatment of HER2 low metastatic breast cancer has been discussed, including with Breast Cancer Now and other campaigners. The Government wants patients to be able to benefit from access to innovative and effective new treatments such as Enhertu at a price that fairly reflects the benefits that they bring to patients, and does not displace funding for other valuable treatments and services. The National Institute for Health and Care Excellence and NHS England have been clear with the companies that the price represents the main barrier to access to Enhertu for patients with HER2 low breast cancer, and we encourage the companies to come forward with an improved commercial offer.

Written Answers

Trastuzumab Deruxtecan
Asked by: Alistair Strathern (Labour - Hitchin)
Monday 28th October 2024

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent discussions he has had on the provision of Enhurtu to Her2 low metastatic breast cancer patients.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department’s ministers and officials have had a number of recent meetings at which the issue of the availability of Enhertu for the treatment of HER2 low metastatic breast cancer has been discussed, including with Breast Cancer Now and other campaigners.

The Government wants patients to be able to benefit from access to innovative and effective new treatments such as Enhertu at a price that fairly reflects the benefits that they bring to patients, and does not displace funding for other valuable treatments and services. The National Institute for Health and Care Excellence and NHS England have been clear with the companies that the price represents the main barrier to access to Enhertu for patients with HER2 low breast cancer, and we encourage the companies to come forward with an improved commercial offer.

Alistair Strathern mentioned

Parliamentary Debates
Budget Resolutions 280 speeches (48,171 words) Wednesday 6th November 2024 - Commons Chamber Department for Business and Trade Mentions: 1: Graham Stuart (Con - Beverley and Holderness) Member for Hitchin (Alistair Strathern) is grinning—I know he grins a lot, but it should not be funny - Link to Speech